+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Arbovirus Testing Market - Global Forecast 2026-2032- Product Image
Arbovirus Testing Market - Global Forecast 2026-2032- Product Image
New

Arbovirus Testing Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 181 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5887482
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The arbovirus testing market is reshaping the global diagnostics landscape as leaders prioritize swift detection, integrated surveillance, and resilient response strategies to address expanding vector-borne disease risks. This report distills essential insights enabling informed decisions in procurement, operations, and investment within a complex, rapidly changing environment.

Market Snapshot: Arbovirus Testing Market Growth and Direction

The arbovirus testing market demonstrated strong momentum, advancing from USD 1.39 billion in 2025 to USD 1.48 billion in 2026 and is set to reach USD 2.20 billion by 2032, propelled by a CAGR of 6.72%. These trends reflect heightened demand driven by more frequent outbreaks, mandatory enhancements in surveillance, and innovations sharpening detection across public health, veterinary, and environmental contexts. Dynamic coordination between clinical care and public health frameworks is now fundamental, pushing diagnostic procurement, technology adoption, and supplier strategies at both local and global levels.

Scope & Segmentation: Illuminating Strategic Differences Across Arbovirus Diagnostics

  • Test Types: Molecular diagnostics enable direct pathogen identification, serological assays monitor immune responses, and rapid diagnostic tests facilitate point-of-care applications beyond central labs.
  • Assay Technologies: Real-time and digital PCR support precise quantification, while ELISA formats—competitive, indirect, and sandwich—provide versatility. Lateral flow devices offer convenience, and microarray technologies address multiplex or high-throughput requirements for resource-intensive settings.
  • End User: Diagnostic laboratories, hospital networks, research institutes, pharmaceutical companies, and veterinary clinics each select technologies based on sample volume, throughput, and integration with broader operational workflows.
  • Application Use Cases: Testing platforms support acute patient diagnosis, epidemiological surveillance, veterinary monitoring, and research initiatives demanding high sensitivity and scalable processing.
  • Sample Matrix: Assays validated for plasma, saliva, serum, urine, and whole blood address a variety of clinical and logistical challenges, optimizing adaptability for field-based and centralized applications.
  • Geographical Regions: The analysis examines adoption trends and regulatory requirements across the Americas, Europe, Middle East & Africa, and Asia-Pacific, highlighting regional disparities influencing strategy and procurement.

Key Takeaways: Strategic Insights for Senior Decision-Makers

  • The shift toward adaptive diagnostic platforms that balance sensitivity with scale is central to outbreak containment and routine monitoring.
  • Robust integration of laboratory outputs with epidemiological and geospatial data supports more effective vector control and public health deployment.
  • One Health approaches are uniting human, animal, and environmental diagnostics—driving collaboration and accelerating solution development across sectors.
  • Regional manufacturing investments are mitigating supply vulnerabilities, enabling faster distribution and response capabilities during crises.
  • Supplier strategies increasingly focus on redundancy and modularity so organizations can flexibly respond to variable regulatory environments and shifting demand patterns.
  • Segmentation by end user and specimen type is pivotal, as distinct operational needs require tailored validation, processing capacity, and workflow compatibility.

Tariff Impact: 2025 Policy Shifts and Strategic Responses

Changes in tariff policy in 2025 reshaped procurement and manufacturing in the arbovirus diagnostics sector. Laboratories must now closely assess reagent and equipment sourcing, resulting in longer procurement cycles and higher scrutiny at leadership levels. In response, manufacturers are bolstering regional production, validating new supply chains, and strengthening supplier networks. Both industry and academic R&D are reallocating resources toward platform-agnostic development to minimize dependency on single-source suppliers.

Methodology & Data Sources

This report is built on comprehensive primary interviews with laboratory directors, clinicians, regulators, and procurement specialists. Insights were triangulated with peer-reviewed literature, technical documentation, supplier mapping efforts, and regional regulatory guidelines to ensure data accuracy and actionable conclusions.

Why This Report Matters

  • Helps executive leaders align diagnostic procurement and operational strategy with evolving risk profiles and technology advancements.
  • Delivers a clear perspective on policy shifts, regional differences, and cross-sector collaborations shaping readiness and supply resilience.
  • Supports investment planning through sharp segmentation, actionable guidance, and in-depth supplier and regulation analysis.

Conclusion: Strategic Imperatives for Arbovirus Diagnostic Readiness

Preparedness in the arbovirus testing market depends on coordinated action spanning technology, supply chain strategy, and cross-sector partnerships. Adaptive leaders investing in robust diagnostics and integrated data workflows will enhance public health outcomes and ongoing operational resilience.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Arbovirus Testing Market, by Test Type
8.1. Molecular Tests
8.2. Rapid Diagnostic Tests
8.3. Serological Tests
9. Arbovirus Testing Market, by Technology
9.1. ELISA
9.1.1. Competitive ELISA
9.1.2. Indirect ELISA
9.1.3. Sandwich ELISA
9.2. Lateral Flow Assays
9.2.1. Competitive Assay
9.2.2. Sandwich Assay
9.3. Microarray
9.3.1. DNA Microarray
9.3.2. Protein Microarray
9.4. PCR Technology
9.4.1. Conventional PCR
9.4.2. Digital PCR
9.4.3. Real-Time PCR
10. Arbovirus Testing Market, by Sample Type
10.1. Plasma
10.2. Saliva
10.3. Serum
10.4. Urine
10.5. Whole Blood
11. Arbovirus Testing Market, by Application
11.1. Clinical Diagnostics
11.2. Epidemiological Surveillance
11.3. Veterinary Testing
12. Arbovirus Testing Market, by End User
12.1. Diagnostic Laboratories
12.2. Hospitals
12.3. Pharmaceutical Companies
12.4. Research Institutions
13. Arbovirus Testing Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Arbovirus Testing Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Arbovirus Testing Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Arbovirus Testing Market
17. China Arbovirus Testing Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Abbott Laboratories
18.6. Becton, Dickinson and Company
18.7. bioMérieux SA
18.8. Controllab
18.9. Danaher Corporation
18.10. F. Hoffmann-La Roche AG
18.11. Hangzhou Clongene Biotech Co., Ltd.
18.12. Hologic, Inc.
18.13. PerkinElmer, Inc.
18.14. QIAGEN N.V.
18.15. Response Biomedical Corp.
18.16. Siemens Healthineers AG
18.17. Thermo Fisher Scientific Inc.
List of Figures
FIGURE 1. GLOBAL ARBOVIRUS TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL ARBOVIRUS TESTING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL ARBOVIRUS TESTING MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES ARBOVIRUS TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA ARBOVIRUS TESTING MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL ARBOVIRUS TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY MOLECULAR TESTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY MOLECULAR TESTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY MOLECULAR TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TESTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TESTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY SEROLOGICAL TESTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY SEROLOGICAL TESTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY SEROLOGICAL TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY ELISA, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY ELISA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY ELISA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY COMPETITIVE ELISA, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY COMPETITIVE ELISA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY COMPETITIVE ELISA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY INDIRECT ELISA, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY INDIRECT ELISA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY INDIRECT ELISA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY SANDWICH ELISA, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY SANDWICH ELISA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY SANDWICH ELISA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY COMPETITIVE ASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY COMPETITIVE ASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY COMPETITIVE ASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY SANDWICH ASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY SANDWICH ASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY SANDWICH ASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY DNA MICROARRAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY DNA MICROARRAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY DNA MICROARRAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY PROTEIN MICROARRAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY PROTEIN MICROARRAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY PROTEIN MICROARRAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY CONVENTIONAL PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY CONVENTIONAL PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY CONVENTIONAL PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY DIGITAL PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY DIGITAL PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY REAL-TIME PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY REAL-TIME PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY PLASMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY PLASMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY PLASMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY SALIVA, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY SALIVA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY SALIVA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY SERUM, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY SERUM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY SERUM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY URINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY URINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY URINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY WHOLE BLOOD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY WHOLE BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY VETERINARY TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY VETERINARY TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY VETERINARY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. AMERICAS ARBOVIRUS TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 100. AMERICAS ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 101. AMERICAS ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 102. AMERICAS ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2032 (USD MILLION)
TABLE 103. AMERICAS ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2032 (USD MILLION)
TABLE 104. AMERICAS ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2032 (USD MILLION)
TABLE 105. AMERICAS ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 106. AMERICAS ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 107. AMERICAS ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 108. AMERICAS ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 109. NORTH AMERICA ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. NORTH AMERICA ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 111. NORTH AMERICA ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 112. NORTH AMERICA ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2032 (USD MILLION)
TABLE 113. NORTH AMERICA ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2032 (USD MILLION)
TABLE 114. NORTH AMERICA ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2032 (USD MILLION)
TABLE 115. NORTH AMERICA ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 116. NORTH AMERICA ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 117. NORTH AMERICA ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 119. LATIN AMERICA ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. LATIN AMERICA ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 121. LATIN AMERICA ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 122. LATIN AMERICA ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2032 (USD MILLION)
TABLE 123. LATIN AMERICA ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2032 (USD MILLION)
TABLE 124. LATIN AMERICA ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2032 (USD MILLION)
TABLE 125. LATIN AMERICA ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 126. LATIN AMERICA ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 127. LATIN AMERICA ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA ARBOVIRUS TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2032 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2032 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2032 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 139. EUROPE ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 140. EUROPE ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 141. EUROPE ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 142. EUROPE ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2032 (USD MILLION)
TABLE 143. EUROPE ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2032 (USD MILLION)
TABLE 144. EUROPE ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2032 (USD MILLION)
TABLE 145. EUROPE ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 146. EUROPE ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 147. EUROPE ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 148. EUROPE ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 149. MIDDLE EAST ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. MIDDLE EAST ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 151. MIDDLE EAST ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 152. MIDDLE EAST ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2032 (USD MILLION)
TABLE 153. MIDDLE EAST ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2032 (USD MILLION)
TABLE 154. MIDDLE EAST ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2032 (USD MILLION)
TABLE 155. MIDDLE EAST ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 156. MIDDLE EAST ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 157. MIDDLE EAST ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 158. MIDDLE EAST ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 159. AFRICA ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 160. AFRICA ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 161. AFRICA ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 162. AFRICA ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2032 (USD MILLION)
TABLE 163. AFRICA ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2032 (USD MILLION)
TABLE 164. AFRICA ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2032 (USD MILLION)
TABLE 165. AFRICA ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 166. AFRICA ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 167. AFRICA ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 168. AFRICA ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 169. ASIA-PACIFIC ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 170. ASIA-PACIFIC ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 171. ASIA-PACIFIC ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 172. ASIA-PACIFIC ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2032 (USD MILLION)
TABLE 173. ASIA-PACIFIC ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2032 (USD MILLION)
TABLE 174. ASIA-PACIFIC ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2032 (USD MILLION)
TABLE 175. ASIA-PACIFIC ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 176. ASIA-PACIFIC ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 177. ASIA-PACIFIC ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 178. ASIA-PACIFIC ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 179. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 180. ASEAN ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 181. ASEAN ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 182. ASEAN ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 183. ASEAN ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2032 (USD MILLION)
TABLE 184. ASEAN ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2032 (USD MILLION)
TABLE 185. ASEAN ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2032 (USD MILLION)
TABLE 186. ASEAN ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 187. ASEAN ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 188. ASEAN ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 189. ASEAN ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 190. GCC ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 191. GCC ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 192. GCC ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 193. GCC ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2032 (USD MILLION)
TABLE 194. GCC ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2032 (USD MILLION)
TABLE 195. GCC ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2032 (USD MILLION)
TABLE 196. GCC ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 197. GCC ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 198. GCC ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 199. GCC ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 200. EUROPEAN UNION ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 201. EUROPEAN UNION ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 202. EUROPEAN UNION ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 203. EUROPEAN UNION ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2032 (USD MILLION)
TABLE 204. EUROPEAN UNION ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2032 (USD MILLION)
TABLE 205. EUROPEAN UNION ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2032 (USD MILLION)
TABLE 206. EUROPEAN UNION ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 207. EUROPEAN UNION ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 208. EUROPEAN UNION ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 209. EUROPEAN UNION ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 210. BRICS ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 211. BRICS ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 212. BRICS ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 213. BRICS ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2032 (USD MILLION)
TABLE 214. BRICS ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2032 (USD MILLION)
TABLE 215. BRICS ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2032 (USD MILLION)
TABLE 216. BRICS ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 217. BRICS ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 218. BRICS ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 219. BRICS ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 220. G7 ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 221. G7 ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 222. G7 ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 223. G7 ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2032 (USD MILLION)
TABLE 224. G7 ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2032 (USD MILLION)
TABLE 225. G7 ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2032 (USD MILLION)
TABLE 226. G7 ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 227. G7 ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 228. G7 ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 229. G7 ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 230. NATO ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 231. NATO ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 232. NATO ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 233. NATO ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2032 (USD MILLION)
TABLE 234. NATO ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2032 (USD MILLION)
TABLE 235. NATO ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2032 (USD MILLION)
TABLE 236. NATO ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 237. NATO ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 238. NATO ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 239. NATO ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 240. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 241. UNITED STATES ARBOVIRUS TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 242. UNITED STATES ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 243. UNITED STATES ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 244. UNITED STATES ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2032 (USD MILLION)
TABLE 245. UNITED STATES ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2032 (USD MILLION)
TABLE 246. UNITED STATES ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2032 (USD MILLION)
TABLE 247. UNITED STATES ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 248. UNITED STATES ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 249. UNITED STATES ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 250. UNITED STATES ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 251. CHINA ARBOVIRUS TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 252. CHINA ARBOVIRUS TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 253. CHINA ARBOVIRUS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 254. CHINA ARBOVIRUS TESTING MARKET SIZE, BY ELISA, 2018-2032 (USD MILLION)
TABLE 255. CHINA ARBOVIRUS TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2032 (USD MILLION)
TABLE 256. CHINA ARBOVIRUS TESTING MARKET SIZE, BY MICROARRAY, 2018-2032 (USD MILLION)
TABLE 257. CHINA ARBOVIRUS TESTING MARKET SIZE, BY PCR TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 258. CHINA ARBOVIRUS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 259. CHINA ARBOVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 260. CHINA ARBOVIRUS TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Arbovirus Testing market report include:
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • bioMérieux SA
  • Controllab
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Hangzhou Clongene Biotech Co., Ltd.
  • Hologic, Inc.
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Response Biomedical Corp.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages181
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.48 Billion
Forecasted Market Value ( USD ) by 2032 $ 2.2 Billion
Compound Annual Growth Rate6.7%
Regions CoveredGlobal
No. of Companies Mentioned14

Related Topics

Related Reports

Arbovirus Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Arbovirus Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 210 Pages
  • Global
From
Arbovirus Testing Market Size, Share & Trends Analysis Report by Type (ELISA-Based Tests, RT-PCR Based Tests), End-use (Diagnostic Laboratories, Hospitals, Research Centers), Region, with Growth Forecasts, 2025-2030 - Product Image

Arbovirus Testing Market Size, Share & Trends Analysis Report by Type (ELISA-Based Tests, RT-PCR Based Tests), End-use (Diagnostic Laboratories, Hospitals, Research Centers), Region, with Growth Forecasts, 2025-2030

  • Report
  • 110 Pages
  • Global
From
Arbovirus Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Arbovirus Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 185 Pages
  • Global
From
Arbovirus Testing Market - Tests, Viruses & End-users - Product Image

Arbovirus Testing Market - Tests, Viruses & End-users

  • Report
  • 266 Pages
  • Global
From
Arbovirus Testing - Global Strategic Business Report - Product Image

Arbovirus Testing - Global Strategic Business Report

  • Report
  • 173 Pages
  • Global
From

About the Arbovirus Testing Market

The Arbovirus Testing market is a subset of the larger Infectious Disease Testing market. It is focused on the detection of arboviruses, which are a group of viruses transmitted by arthropods such as mosquitoes, ticks, and sandflies. These viruses can cause a range of illnesses, including dengue, chikungunya, Zika, and yellow fever. Arbovirus Testing is used to diagnose and monitor these diseases, as well as to track the spread of arboviruses in a given population. Arbovirus Testing is typically performed using molecular techniques such as PCR and RT-PCR, as well as serological methods such as ELISA and immunofluorescence. These tests are available from a variety of companies, including Abbott, Bio-Rad, Cepheid, DiaSorin, Hologic, and Roche. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.